Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the cardiac ablation market and it is poised to grow by $ 1.67 bn during 2021-2025, progressing at a CAGR of 7.51% during the forecast period. Our report on cardiac ablation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of cardiac diseases and the growth of insurance providers, minimally invasive procedures with improved medical imaging, and the growing focus on clinical trials.
The cardiac ablation market analysis includes the product segment and geographic landscape.
The cardiac ablation market is segmented as below:
By Product
- Cardiac ablation catheters
- Cardiac ablation devices
By Geography
- North America
- Europe
- Asia
- ROW
This study identifies the transforming marketing and sales strategies for cardiac ablation as one of the prime reasons driving the cardiac ablation market growth during the next few years. Also, the emergence of digital cath labs in hospitals and the integration of robotic cardiac catheter systems and hybrid operating room equipment will lead to sizable demand in the market.
The report on cardiac ablation market covers the following areas:
- Cardiac ablation market sizing
- Cardiac ablation market forecast
- Cardiac ablation market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiac ablation market vendors that include Abbott Laboratories, AngioDynamics Inc., AtriCure Inc., Boston Scientific Corp., CONMED Corp., DVx Inc., Imricor Medical Systems Inc., Johnson and Johnson Inc., Medtronic Plc, and Olympus Corp. Also, the cardiac ablation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global cardiac ablation market: Abbott Laboratories, AngioDynamics Inc., AtriCure Inc., Boston Scientific Corp., CONMED Corp., DVx Inc., Imricor Medical Systems Inc., Johnson and Johnson Inc., Medtronic Plc, and Olympus Corp.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is transforming marketing and sales strategies for cardiac ablation.`
According to the report, one of the major drivers for this market is the rising incidence of cardiac diseases and the growth of insurance providers.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AngioDynamics Inc.
- AtriCure Inc.
- Boston Scientific Corp.
- CONMED Corp.
- DVx Inc.
- Imricor Medical Systems Inc.
- Johnson and Johnson Inc.
- Medtronic Plc
- Olympus Corp.
